Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Former National Coordinator for Health IT Farzad Mostashari, MD, MSc, has launched a national campaign to drive better patient access to healthcare data.
FDA-regulated digital health solutions are expected to save the U.S. healthcare system about $100 billion over the next four years, according to research released by Accenture.
The American Medical Association (AMA) and American Hospital Association (AHA) have released a new set of guiding principles for bringing clinical skills and business insights together at the leadership level to foster more collaborative and cohesive decision-making at hospitals and health systems.
SPRINGFIELD, Mo., June 3, 2015 /PRNewswire/ -- National Endeavors, LLC, announces a new, comprehensive and low cost option for potential Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) applicants.
MORRISVILLE, N.C., June 3, 2015 (GLOBE NEWSWIRE) -- Study Connect(TM), a new mobile app from Merge eClinical, allows eClinicalOS (eCOS) users to perform a wide array of clinical trial management functions from their iOS-based mobile devices.
The global mobile health market is expected to grow at a compound annual growth rate of 33.5 percent between 2015 and 2020, according to Allied Market Research.
An initial public offering of Fitbit, the maker of wearable devices that collect data on exercise and sleep patterns, could top $500 million, according to mulitiple reports.
West Palm Beach, FL - June 2, 2015 – Comvest Partners, with co-investor Mosaic Health Solutions, today announced it has completed the acquisition of McKesson Corporation’s Care Management business, which will be renamed AxisPoint Health (“the Company”).
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
